Search
Botanix executive chairman Vince Ippolito was positive about the results, particularly the Australian data.

Botanix shares plunge on study results

Shares in Bentley-based medical cannabis company Botanix Pharmaceuticals have nearly halved, after it released the results of its clinical trial for acne treatment.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 30/04/20

1 year TSR5 year TSR
68thOBJ117%33%
289thResApp Health3%82%
687thBotanix Pharmaceuticals-54%12%
827thDXN-84%
674 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

08/05/20
$0 Other
21/02/20
$0 Other
11/12/19
$27k Other
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

93rd↑Botanix Pharmaceuticals$4.7m
104th↑ResApp Health$2.7m
105th↑OBJ$61.6m
108th-DXN$2.6m
109th↑Affinity Energy and Health$2.6m
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®